A detailed history of Brown, Lisle/Cummings, Inc. transactions in Walgreens Boots Alliance, Inc. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 28,082 shares of WBA stock, worth $265,655. This represents 0.08% of its overall portfolio holdings.

Number of Shares
28,082
Previous 29,734 5.56%
Holding current value
$265,655
Previous $360 Million 30.03%
% of portfolio
0.08%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$8.26 - $12.16 $13,645 - $20,088
-1,652 Reduced 5.56%
28,082 $252 Million
Q2 2024

Jul 17, 2024

BUY
$12.1 - $19.54 $66,259 - $107,001
5,476 Added 22.57%
29,734 $360 Million
Q1 2024

Jun 28, 2024

BUY
$20.51 - $26.65 $72,707 - $94,474
3,545 Added 17.11%
24,258 $526 Million
Q4 2023

Jun 28, 2024

BUY
$19.94 - $26.64 $14,456 - $19,314
725 Added 3.63%
20,713 $541 Million
Q3 2023

Jun 28, 2024

BUY
$20.9 - $30.85 $163,897 - $241,925
7,842 Added 64.56%
19,988 $445 Million
Q2 2023

Jun 28, 2024

BUY
$28.37 - $36.31 $113,650 - $145,457
4,006 Added 49.21%
12,146 $346 Million
Q1 2023

Jun 28, 2024

BUY
$32.33 - $37.71 $58,355 - $68,066
1,805 Added 28.49%
8,140 $281 Million
Q4 2022

Jun 28, 2024

BUY
$30.52 - $41.79 $6,256 - $8,566
205 Added 3.34%
6,335 $237 Million
Q3 2022

Jun 28, 2024

BUY
$31.4 - $42.04 $12,717 - $17,026
405 Added 7.07%
6,130 $192 Million
Q2 2022

Jun 28, 2024

BUY
$37.9 - $46.81 $5,836 - $7,208
154 Added 2.76%
5,725 $217 Million
Q1 2022

Jun 28, 2024

BUY
$44.77 - $54.33 $18,087 - $21,949
404 Added 7.82%
5,571 $249 Million
Q4 2021

Jun 28, 2024

BUY
$43.72 - $52.25 $225,901 - $269,975
5,167 New
5,167 $270 Million

Others Institutions Holding WBA

About Walgreens Boots Alliance, Inc.


  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $8.18B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Brown, Lisle/Cummings, Inc. Portfolio

Follow Brown, Lisle/Cummings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.